Pre-stimulation parameters predicting live birth after IVF in the long GnRH agonist protocol

Reproductive BioMedicine Online

Volumn 20, Issue 5, 2010, Pages 572-581

  Pettersson, Göran ^a   Nyboe Andersen, Anders ^b   Broberg, Per ^a   Arce, Joan Carles ^a  

^a Ferring Pharmaceuticals AS   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

In vitro fertilization; Infertility; Live birth; Pre stimulation parameters; Prediction model

Indexed keywords

ANDROSTENEDIONE; GONADORELIN AGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LONG ACTING DRUG; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIPTORELIN;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EMBRYO; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GONADORELIN TEST; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE INFERTILITY; OUTCOME ASSESSMENT; PHARMACOLOGICAL STIMULATION; RETROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; THICKNESS; TREATMENT DURATION; TREATMENT PLANNING; UTERINE TUBE DISEASE;

EID: 77952877242     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.02.014     Document Type: Article

References (44)

1. Arce, J.C., Nyboe Andersen, A., Collins, J., 2005. Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review. Hum. Reprod. 20, 1757-1771.
2. ASRM/SART Registry, 2007. Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry. Fertil. Steril. 87, 1253-1266.
3. Bancsi, L.F.J.M.M., Broekmans, F.J.M., Eijkemans, M.J.C., et al., 2002. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil. Steril. 77, 328-336.
4. Broekmans, F.J., Klinkert, E.R., 2004. Female age in ART: when to stop. Gynecol. Obstet. Invest. 58, 225-234.
5. Broekmans, F.J., Kwee, J., Hendriks, D.J., et al., 2006. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update 12, 685-718.
6. Broer, S.L., Mol, B.W., Hendriks, D., et al., 2009. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil. Steril. 91, 705-714.
7. Carrera-Rotllan, Estrada-Garcia, L., Sarquella-Ventura, J., 2007. Prediction of pregnancy in IVF cycles on the fourth day of ovarian stimulation. J. Assist. Reprod. Genet. 24, 387-394.
8. Collins, J.A., Burrow, E.A., Wilan, A.R., 1995. The prognosis for live birth among untreated infertile couples. Fertil. Steril. 64, 22-28.
9. Coppus, S.F., van der Veen, F., Opmeer, B.C., et al., 2009. Evaluating prediction models in reproductive medicine. Hum. Reprod. 24, 1774-1778.
10. Croucher, C.A., Lass, A., Margara, R., et al., 1998. Predictive value of the results of a first in-vitro fertilization cycle on the outcome of subsequent cycles. Hum. Reprod. 13, 403-408.
11. Diamanti-Kandarakis, E., Papailou, J., Palimeri, S., 2006. Hyper-androenemia: pathophysiology and its role in ovulatory dysfunction in PCOS. Pediatr. Endocrinol. Rev. 3, 198-204.
12. Erdem, M., Erdem, A., Gursoy, R., et al., 2004. Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF. J. Assist. Reprod. Genet. 21, 37-45.
13. Gnoth, C., Schuring, A.N., Friol, K., et al., 2008. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum. Reprod. 23, 1359-1365.
14. Gunby, J., Bissonnette, F., Librach, C., et al., 2008. Assisted reproductive technologies (ART) in Canada: 2004 results from the Canadian ART Register. Fertil. Steril. 89, 1123-1132.
15. Hendriks, D.J., Mol, B.W.J.M., Bancsi, L.F.J.M.M., et al., 2005. Antral follicle count in the prediction of poor ovarian response and pregnancy after in-vitro-fertilization: a meta analysis and comparison with basal follicle-stimulating hormone level. Fertil. Steril. 83, 291-301.
16. Hofman, G., Soshowski, J., Scott, R., et al., 1996. Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. Fertil. Steril. 66, 49-53.
17. Hull, M.G., Fleming, C.F., Hughes, A.O., et al., 1996. The age-related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertil. Steril. 65, 783-790.
18. Huirne, J.A., Homburg, R., Lambalk, C.B., 2007. Are GnRH antagonists comparable to agonists for use in IVF? Hum. Reprod. 22, 2805-2813. (Pubitemid 351696806)
19. Hunault, CC, Eijkemans, M.J.C., Pieters, M.H.E.C., et al., 2002. A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertil. Steril. 77, 725-732.
20. Kolibianakis, E.M., Zikopoulos, K., Smitz, J., et al., 2004. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Hum. Reprod. 19, 1525-1529.
21. Kwee, J., Schats, R., McDonnell, J., et al., 2008. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil. Steril. 90, 737-743.
22. Lee, T.H., Liu, C.H., Huang, C.C., et al., 2008. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum. Reprod. 23, 160-167.
23. Leushuis, E., van der Steeg, J.W., Steures, P., et al., 2009. Prediction models in reproductive medicine: a critical appraisal. Hum. Reprod. Update 15, 537-552.
24. Liccardi, F.L., Liu, H.C., Rosenwaks, Z., 1995. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil. Steril. 64, 991-994.
25. Lintsen, A.M., Eijkemans, M.J., Hunault, C.C., et al., 2007. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum. Reprod. 22, 2455-2462.
26. Meldrum, D.R., Silverberg, K.M., Bustillo, M., et al., 1998. Success rate with repeated cycles of in vitro fertilization-embryo transfer. Fertil. Steril. 69, 1005-1009.
27. Nelson, S.M., Yates, R.W., Lyall, H., et al., 2009. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum. Reprod. 24, 867-875.
28. Nyboe Andersen, A., Devroey, P., Arce, J.-C.for the MERIT Group, 2006. Clinical outcome following stimulation with highly purified hMG or recombinant FSH undergoing IVF: a randomized assessor-blind controlled trial. Hum. Reprod. 21, 3217-3227.
29. Ottosen, L.D.M., Kesmodel, U., Hindkjaer, J., et al., 2007. Pregnancy prediction models and eSET criteria for IVF patients-do we need more information? J. Assist. Reprod. Genet. 24, 29-36.
30. R Development Core Team 2008 R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
31. Scott, R.T., Toner, J.P., Muasher, S.J., 1989. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil. Steril. 51, 651-654.
32. Smitz, J., Andersen, A.N., Devroey, P., et al., 2007. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum. Reprod. 22, 676-687.
33. Steptoe, P.C., Edwards, R.G., 1978. Birth after reimplantation of a human embryo. Lancet 2, 366.
34. Stolwijk, A.M., Straatman, H., Zielhuis, G.A., et al., 1998. External validation of prognostic models for ongoing pregnancy after in-vitro fertilization. Hum. Reprod. 13, 3542-3549.
35. Stolwijk, A.M., Zielhuis, G.A., Hamilton, C.J., et al., 1996. Prognostic models for the probability of achieving an ongoing pregnancy after in-vitro fertilization and the importance of testing their predictive value. Hum. Reprod. 11, 2298-2303.
36. Swets, J., 1988. Measuring the accuracy of diagnostic systems. Science 240, 1285-1293.
37. Tarlatzis, B.C., Zepiridis, L., Grimbizis, G., et al., 2003. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum. Reprod. Update 9, 61-76.
38. Templeton, A., Morris, J.K., Parslow, W., 1996. Factors that affect outcome of in-vitro fertilisation treatment. Lancet 348, 1402-1406. (Pubitemid 26395234)
39. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2008. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil. Steril. 89, 505-522.
40. The European IVF-monitoring programme (EIM) for the European Society of Human Reproduction and Embryology (ESHRE) Nyboe Andersen, A., Goossens, V., Ferraretti, A.P., et al., 2004. Assisted reproductive technology in Europe, 2004. Results generated from European registers by ESHRE. Hum. Reprod. 23, 756-771.
41. Thurin, A., Hardarson, T., Hausken, J., 2005. Predictors of ongoing implantation in IVF in a good prognosis group of patients. Hum. Reprod. 20, 1876-1880.
42. Verberg, M.F., Eijkemans, M.J., Macklon, N.S., et al., 2008. Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil. Steril. 89, 1159-1165.
43. Yanushpotsky, E.H., Hurwitz, S., Tikh, E., et al., 2003. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization in women younger than 40 years of age. Fertil. Steril. 80, 111-115.
44. Ziebe, S., Lundin, K., Janssen, R., et al., 2007. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum. Reprod. 22, 2404-2413.